Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.

DiBianco R, Morganroth J, Freitag JA, Ronan JA Jr, Lindgren KM, Donohue DJ, Larca LJ, Chadda KD, Olukotun AY.

Am Heart J. 1984 Oct;108(4 Pt 2):1121-7.

PMID:
6148872
2.

Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.

Kochiadakis GE, Kanoupakis EM, Kalebubas MD, Igoumenidis NE, Vardakis KE, Mavrakis HE, Vardas PE.

Europace. 2001 Jan;3(1):73-9.

PMID:
11271956
4.

Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.

Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK, et al.

Int J Cardiol. 1995 Nov 24;52(2):167-74.

PMID:
8749878
5.

Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.

Ang EL, Chan WL, Cleland JG, Moore D, Krikler SJ, Alexander ND, Oakley CM.

Br Heart J. 1990 Oct;64(4):256-60.

6.

A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.

Lewis RV, Laing E, Moreland TA, Service E, McDevitt DG.

Eur Heart J. 1988 Mar;9(3):279-83.

PMID:
3289931
7.

Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol.

Coumel P, Escoubet B, Attuel P.

Am Heart J. 1984 Oct;108(4 Pt 2):1098-108.

PMID:
6148870
8.

[Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].

Horn HG, Neuss H, Schlepper M, Mitrovic V, Stämmler G.

Med Klin. 1980 Sep 26;75(20):721-5. German.

PMID:
6106885
9.

[Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].

Vitale P, Auricchio A, De Stefano R, Agretto A, De Simone R, Vitale N, Barbato F, Iacono A.

Cardiologia. 1989 Jan;34(1):73-81. Italian.

PMID:
2720716
10.
12.

Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study.

Lang R, Klein HO, Di Segni E, Gefen J, Sareli P, Libhaber C, David D, Weiss E, Guerrero J, Kaplinsky E.

Am Heart J. 1983 May;105(5):820-5.

PMID:
6846125
13.

A comparison of verapamil and digoxin in the treatment of atrial fibrillation.

Lewis R, Lakhani M, Moreland TA, McDevitt DG.

Eur Heart J. 1987 Feb;8(2):148-53.

PMID:
3552680
14.
15.

Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.

Maragno I, Santostasi G, Gaion RM, Trento M, Grion AM, Miraglia G, Dalla Volta S.

Am Heart J. 1988 Aug;116(2 Pt 1):385-92.

PMID:
3400564
16.

Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation.

Zoble RG, Brewington J, Olukotun AY, Gore R.

Am J Cardiol. 1987 Aug 31;60(6):39D-45D.

PMID:
3307366
17.

Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.

Shettigar UR, Toole JG, Appunn DO.

Am Heart J. 1993 Aug;126(2):368-74.

PMID:
8101692
18.
19.
20.

beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.

Hiatt WR, Wolfel EE, Stoll S, Nies AS, Zerbe GO, Brammell HL, Horwitz LD.

Clin Pharmacol Ther. 1985 Jan;37(1):2-6.

PMID:
2856902

Supplemental Content

Support Center